Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.
CEO
Chairperson of the Board
Board
| Name | Capital % | Votes % | Date |
|---|---|---|---|
| Christer Fåhraeus | 11,24 | 11,24 | 2022-06-28 |
| Avanza Pension | 7,34 | 7,34 | 2022-06-28 |
| Valcuria Holding AB | 3,86 | 3,86 | 2022-06-28 |
| Ben Hayes | 2,34 | 2,34 | 2022-06-28 |
| Hans Harvig | 1,72 | 1,72 | 2022-06-28 |
| Wilhelm Risberg | 1,20 | 1,20 | 2022-06-28 |
| Benny Bengtsson | 1,20 | 1,20 | 2022-06-28 |
| Formue Nord A/S | 1,16 | 1,16 | 2022-06-28 |
| Fredrik Lundgren | 1,14 | 1,14 | 2022-06-28 |
| Göran Lennart Rehn | 0,99 | 0,99 | 2022-06-28 |
2022-08-30 Delårsrapport 2022-Q1
2022-11-08 Delårsrapport 2022-Q2
2023-02-07 Bokslutskommuniké 2022